Report copyright - MolMed S.p.A. Company Overview...Juno Therapeutics advancing Global Leadership in cellular Immunotherapy ~ 9 $ Bn Sanofi SA agreed to buy ... Haplo in Acute leukemia DLI. 823 (’16)
Please pass captcha verification before submit form